Menu Search
Equities

Dis-Chem Pharmacies Ltd

2Q6:BER

Dis-Chem Pharmacies Ltd

Actions
  • Price (EUR)1.97
  • Today's Change0.01 / 0.51%
  • Shares traded--
  • 1 Year change+40.71%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 18:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dis-Chem Pharmacies Limited is a South Africa-based company, which is engaged in the retailing and wholesale of affordable healthcare products and pharmaceuticals. The Company operates through two segments: Retail and Wholesale. The retail segment consists of the Dis-Chem stores, retailers of pharmaceuticals, health, and beauty products, as well as pharma-logistic services, oncology, and retailers of pharmaceutical products. Its retail pharmacy stores are divided into four categories: Dispensary, Personal Care and Beauty, Healthcare and Nutrition, and Baby Care. The Wholesale segment consists of the CJ Wholesale and Dis-Chem Distribution businesses, wholesalers of pharmaceuticals and health and beauty products. The Company operates approximately 273 retail pharmacy stores and 54 retail baby stores.

  • Revenue in ZAR (TTM)37.99bn
  • Net income in ZAR1.06bn
  • Incorporated2005
  • Employees18.50k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.